References:
[1] Merenstein, D., Guzzi, J., & Sanders, M. E. 2019. More
information is needed on probiotic supplement product labels. Journal of general
internal medicine, 34(12), 2735-2737. https://link.springer.com/article/10.1007/s11606-019-05077-5.
[2] Hill,
C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L.,
Canani, R.B., Flint, H.J., Salminen, S. and Calder, P.C., 2014. Expert consensus
document: The International Scientific Association for Probiotics and Prebiotics
consensus statement on the scope and appropriate use of the term probiotic. Nature
reviews Gastroenterology & hepatology.
[3] Food & Drug Administration (FDA). 2020a. Dietary Supplements.
Retrieved November 19th, 2020. https://www.fda.gov/consumers/consumer-updates/dietary-supplements.
[4] Food & Drug Administration (FDA). 2020b. Dietary Supplements
101. Retrieved November 19th, 2020. https://www.fda.gov/consumers/consumer-updates/dietary-supplements.
[5] Degnan,
F.H., 2008. The US Food and Drug Administration and probiotics: regulatory categorization.
Clinical infectious diseases, 46 (Supplement_2), pp. S133-S136.
[6] Food & Drug Administration (FDA). 2020c. Policy Regarding
Quantitative Labeling of Dietary Supplements Containing Live Microbials: Guidance
for Industry. Retrieved November 19th, 2020. https://www.fda.gov/media/115730/download.
[7] Cohen,
P.A., 2018. Probiotic safety—no guarantees. JAMA internal medicine, 178(12),
pp.1577-1578.
[8] Dailey,
Z., Sanders, M.E. and Merenstein, D., 2020. Retail refrigerated probiotic foods
and their association with evidence of health benefits. Beneficial microbes,
11(2), pp.131-133.
[9] Gibson,
G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J.,
Scott, K., Stanton, C., Swanson, K.S., Cani, P.D. and Verbeke, K., 2017. Expert
consensus document: The International Scientific Association for Probiotics and
Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.
Nature Reviews Gastroenterology & hepatology, 14(8), pp.491-502.
[10] Scherer,
R.W., Huynh, L., Ervin, A.M., Taylor, J. and Dickersin, K., 2013. Clinical Trials.
Gov registration can supplement the information in abstracts for systematic reviews:
a comparison study. BMC medical research methodology, 13(1), pp.1-9.
[11] Souza, M.T.D., Silva, M.D.D. and Carvalho, R.D., 2010.
Integrative review: what is it? How to do it? Einstein (São Paulo), 8, pp.102-106.
[12] Harris, J.D., Quatman, C.E., Manring, M.M., Siston, R.A.
and Flanigan, D.C., 2014. How to write a systematic review. The American Journal
of sports medicine, 42(11), pp.2761-2768.
[13] Williams,
N.T., 2010. Probiotics. American Journal of Health-System Pharmacy, 67(6),
pp.449-458.
[14] Food & Drug Administration (FDA). 2020c. Good Clinical
Practices. Retrieved September 13th, 2020. https://www.fda.gov/ScienceResearch.
[15] Saldanha,
L.G., 2008. US Food and Drug Administration regulations governing label claims for
food products, including probiotics. Clinical infectious diseases, 46
(Supplement_2), pp. S119-S121.
[16] Freedman,
S.B., Williamson-Urquhart, S., Farion, K.J., Gouin, S., Willan, A.R., Poonai, N.,
Hurley, K., Sherman, P.M., Finkelstein, Y., Lee, B.E., and Pang, X.L., 2018. Multicenter
trial of a combination probiotic for children with gastroenteritis. New England
Journal of Medicine, 379(21), pp.2015-2026.
[17] Goldenberg,
J.Z., Yap, C., Lytvyn, L., Lo, C.K.F., Beardsley, J., Mertz, D. and Johnston, B.C.,
2017. Probiotics for the prevention of Clostridium difficile‐associated diarrhea
in adults and children. Cochrane Database of Systematic Reviews, (12).
[18] Isolauri,
E., Salminen, S. and Ouwehand, A.C., 2004. Probiotics. Best practice & research
Clinical gastroenterology, 18(2), pp.299-313.
[19] Sung,
V., D’Amico, F., Cabana, M.D., Chau, K., Koren, G., Savino, F., Szajewska, H., Deshpande,
G., Dupont, C., Indrio, F. and Mentula, S., 2018. Lactobacillus reuteri to treat
infant colic: a meta-analysis. Pediatrics, 141(1).
[20] Health
Canada. 2020. Compendium of Monographs. Retrieved December
14th, 2020. https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/compendium-monographs.html.
[21] Sanders,
M.E., Akkermans, L.M., Haller, D., Hammerman, C., Heimbach, J.T., Hörmannsperger,
G. and Huys, G., 2010. Safety assessment of probiotics for human use. Gut microbes,
1(3), pp.164-185.
[22] Snydman,
D.R., 2008. The safety of probiotics. Clinical infectious diseases, 46(Supplement_2),
pp. S104-S111.